Unicycive Therapeutics Ownership | Who Owns Unicycive Therapeutics?

Unicycive Therapeutics Ownership Summary

Unicycive Therapeutics is owned by 69.36% institutional investors, 6.12% insiders, and 24.52% retail investors. Great point partners is the largest institutional shareholder, holding 12.35% of UNCY shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.74% of its assets in Unicycive Therapeutics shares.

UNCY Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Unicycive Therapeutics	69.36%	6.12%	24.52%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Great point partners	10.98M	12.35%	$8.72M
Nantahala capital management	10.39M	11.68%	$8.25M
Octagon capital advisors lp	10.00M	11.24%	$7.94M
Vivo capital	9.97M	11.21%	$7.92M
Logos global management lp	5.08M	5.71%	$4.03M
Walleye capital	5.00M	5.62%	$3.97M
Silverarc capital management	2.49M	2.80%	$1.97M
Acuta capital partners	2.30M	2.59%	$1.83M
Alyeska investment group	1.75M	1.97%	$1.39M
Altium capital management lp	1.47M	1.66%	$1.17M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Great point partners	10.98M	4.11%	$8.72M
Acuta capital partners	2.30M	1.84%	$1.83M
Octagon capital advisors lp	10.00M	1.31%	$7.94M
Vivo capital	9.97M	0.89%	$7.92M
Logos global management lp	5.08M	0.47%	$4.03M
Silverarc capital management	2.49M	0.43%	$1.97M
Nantahala capital management	10.39M	0.35%	$8.25M
Altium capital management lp	1.47M	0.33%	$1.17M
Xtx topco	171.46K	0.01%	$136.18K
Walleye capital	5.00M	0.01%	$3.97M

Top Buyers

Holder	Shares	% Assets	Change
Nantahala capital management	10.39M	0.35%	7.57M
Vivo capital	9.97M	0.89%	5.50M
Great point partners	10.98M	4.11%	2.42M
Octagon capital advisors lp	10.00M	1.31%	1.44M
Acuta capital partners	2.30M	1.84%	323.80K

Top Sellers

Holder	Shares	% Assets	Change
Ra capital management	-	-	-2.63M
Bvf inc/il	-	-	-2.20M
Rosalind advisors	-	-	-1.57M
Silverarc capital management	2.49M	0.43%	-1.51M
Monashee investment management	-	-	-1.00M

New Positions

Holder	Shares	% Assets	Change	Value
Blackrock	51.84K	-	51.84K	$25.98K
Hrt financial lp	22.13K	0.00%	22.13K	$17.00K
Hunter associates investment management	15.00K	0.00%	15.00K	$12.00K
Soa wealth advisors, llc.	1.00K	0.00%	1.00K	$794.00
Citigroup	587.00	-	587.00	$466.00

Sold Out

Holder	Change
Wells fargo & company/mn	-196.00
Redwood wealth management group	-3.00K
Integrated wealth concepts	-10.00K
Scientech research	-10.97K
Captrust financial advisors	-18.80K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	30	7.14%	61,690,744	31.86%	69	2.51%	20	-9.09%	5	-
Sep 30, 2024	28	16.67%	46,786,564	146.28%	52	1.78%	22	100.00%	-	-100.00%
Jun 30, 2024	24	4.35%	18,997,260	-10.59%	54	0.73%	11	-26.67%	7	250.00%
Mar 31, 2024	23	43.75%	21,247,089	63.05%	86	5.43%	15	114.29%	2	-33.33%
Dec 31, 2023	16	-	13,030,671	-8.19%	39	0.46%	7	-12.50%	3	-25.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	765.00K	0.74%	-
Vanguard Institutional Extnd Mkt Idx Tr	373.22K	0.36%	-
Fidelity Extended Market Index	281.92K	0.27%	-1.80K
iShares Micro-Cap ETF	77.24K	0.07%	-
Fidelity Total Market Index	71.29K	0.07%	-
Fidelity Series Total Market Index	62.44K	0.06%	8.40K
Northern Trust Extended Eq Market Idx	56.58K	0.05%	34.18K
Spartan Extended Market Index Pool E	55.84K	0.05%	1.80K
NT Ext Equity Mkt Idx Fd - L	56.58K	0.05%	-
Spartan Extended Market Index Pool F	55.84K	0.05%	1.80K

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 16, 2022	Schiller Brigitte		Buy	$12.38K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	-
2023 Q3	-	-

UNCY Ownership FAQ

Who Owns Unicycive Therapeutics?

Unicycive Therapeutics shareholders are primarily institutional investors at 69.36%, followed by 6.12% insiders and 24.52% retail investors. The average institutional ownership in Unicycive Therapeutics's industry, Biotech Stocks , is 68.48%, which Unicycive Therapeutics exceeds.

Who owns the most shares of Unicycive Therapeutics?

Unicycive Therapeutics’s largest shareholders are Great point partners (10.98M shares, 12.35%), Nantahala capital management (10.39M shares, 11.68%), and Octagon capital advisors lp (10M shares, 11.24%). Together, they hold 35.27% of Unicycive Therapeutics’s total shares outstanding.

Does Blackrock own Unicycive Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Unicycive Therapeutics.

Who is Unicycive Therapeutics’s biggest shareholder by percentage of total assets invested?

Great point partners is Unicycive Therapeutics’s biggest shareholder by percentage of total assets invested, with 4.11% of its assets in 10.98M Unicycive Therapeutics shares, valued at 8.72M$.

Who is the top mutual fund holder of Unicycive Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Unicycive Therapeutics shares, with 0.74% of its total shares outstanding invested in 765K Unicycive Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools